Vanguard Group
SMTI icon

Vanguard Group’s Sanara MedTech SMTI Stock Holding History

Vanguard Group’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$4.28M Buy
183,137
+1,105
+0.6% +$28.5K ﹤0.01% 3315
2025
Q3 		$5.78M Buy
182,032
+6,049
+3% +$183K ﹤0.01% 3226
2025
Q2 		$5M Sell
175,983
-20,483
-10% -$614K ﹤0.01% 3218
2025
Q1 		$6.06M Sell
196,466
-4,326
-2% -$147K ﹤0.01% 3100
2024
Q4 		$6.67M Buy
200,792
+27,780
+16% +$942K ﹤0.01% 3147
2024
Q3 		$5.23M Buy
173,012
+27,453
+19% +$856K ﹤0.01% 3263
2024
Q2 		$4.11M Buy
145,559
+1,165
+0.8% +$36.6K ﹤0.01% 3337
2024
Q1 		$5.34M Buy
144,394
+4,348
+3% +$163K ﹤0.01% 3278
2023
Q4 		$5.76M Buy
140,046
+4,403
+3% +$141K ﹤0.01% 3224
2023
Q3 		$4.22M Buy
135,643
+4,657
+4% +$180K ﹤0.01% 3322
2023
Q2 		$5.25M Buy
130,986
+23,799
+22% +$974K ﹤0.01% 3271
2023
Q1 		$4.42M Buy
107,187
+11,128
+12% +$469K ﹤0.01% 3364
2022
Q4 		$4.37M Buy
96,059
+3,761
+4% +$130K ﹤0.01% 3367
2022
Q3 		$2.74M Buy
92,298
+100
+0.1% +$2.8K ﹤0.01% 3617
2022
Q2 		$1.92M Hold
92,198
– – ﹤0.01% 3822
2022
Q1 		$2.63M Sell
92,198
-313
-0.3% -$7.94K ﹤0.01% 3848
2021
Q4 		$2.73M Buy
92,511
+7,933
+9% +$250K ﹤0.01% 3918
2021
Q3 		$2.9M Buy
84,578
+18
+0% +$645 ﹤0.01% 3929
2021
Q2 		$3.12M Buy
84,560
+7,412
+10% +$217K ﹤0.01% 3821
2021
Q1 		$2.4M Buy
77,148
+17,947
+30% +$622K ﹤0.01% 3824
2020
Q4 		$2.95M Buy
+59,201
New +$2.33M ﹤0.01% 3557

Other funds holding SMTI

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Group's SMTI Position: Q4 2025 in Review

Vanguard Group increased its Sanara MedTech (SMTI) stake by 0.61% in Q4 2025, buying an estimated $28.5K and bringing the position to 183,137 shares worth $4.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3315.

Vanguard Group first reported a position in SMTI in Q4 2020 and has held it in 21 quarters since. The position peaked at $6.67M in Q4 2024. 53 funds tracked by Wall St. Rank hold SMTI as of Q4 2025.

  • Vanguard Group held 183,137 shares of Sanara MedTech worth $4.28M as of Q4 2025.
  • Vanguard Group bought 1,105 Sanara MedTech shares in Q4 2025, an estimated $28.5K.
  • Sanara MedTech made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3315 holding.
  • Vanguard Group first reported a position in Sanara MedTech in Q4 2020 and has held it in 21 quarters since.
  • Vanguard Group's Sanara MedTech position peaked at $6.67M in Q4 2024.
  • 53 funds tracked by Wall St. Rank held Sanara MedTech as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.